Doxycycline: Difference between revisions

From IDWiki
No edit summary
No edit summary
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
  +
== Background ==
 
* Tetracycline antibiotic
 
* Tetracycline antibiotic
  +
  +
=== Spectrum of Activity ===
 
* Can treat: {{#ask: [[Is treated by::doxycycline]]|default=none}}
  +
  +
=== Distribution ===
  +
  +
* Achieves only low concentrations in the urine, so generally not recommended for UTIs, though some debate about this<ref>Tomasz Jodlowski, Charles R Ashby, Sarath G Nath, Doxycycline for ESBL-E Cystitis, ''Clinical Infectious Diseases'', Volume 73, Issue 1, 1 July 2021, Pages e274–e275, https://doi.org/10.1093/cid/ciaa1898</ref>
  +
  +
== Dosing ==
 
* Usual dosing 100 mg po BID
 
* Usual dosing 100 mg po BID
  +
  +
== Safety ==
  +
  +
=== Adverse Effects ===
 
* Counsel on high risk of sun sensitivity and pill esophagitis
 
* Counsel on high risk of sun sensitivity and pill esophagitis
  +
  +
=== Pregnancy ===
 
* Generally avoid using in pregnant women and children less than 8 years of age due to bone and tooth staining
 
* Generally avoid using in pregnant women and children less than 8 years of age due to bone and tooth staining
 
** However, can often tolerate short courses up to 5 days without issue
 
** However, can often tolerate short courses up to 5 days without issue
* Can treat: {{#ask: [[Is treated by::doxycycline]]|default=none}}
 
   
[[Category:Antibiotics]]
+
[[Category:Tetracyclines]]

Latest revision as of 10:57, 1 November 2023

Background

  • Tetracycline antibiotic

Spectrum of Activity

Distribution

  • Achieves only low concentrations in the urine, so generally not recommended for UTIs, though some debate about this[1]

Dosing

  • Usual dosing 100 mg po BID

Safety

Adverse Effects

  • Counsel on high risk of sun sensitivity and pill esophagitis

Pregnancy

  • Generally avoid using in pregnant women and children less than 8 years of age due to bone and tooth staining
    • However, can often tolerate short courses up to 5 days without issue
  1. Tomasz Jodlowski, Charles R Ashby, Sarath G Nath, Doxycycline for ESBL-E Cystitis, Clinical Infectious Diseases, Volume 73, Issue 1, 1 July 2021, Pages e274–e275, https://doi.org/10.1093/cid/ciaa1898